GlassScriptPhysician profile
Brian R Pecoraro
NPI 1578717989
$5,198.33
in general payments reported to CMS, 2019-2025
26 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,852 · 2020: $849 · 2021: $811 · 2022: $271 · 2023: $222 · 2024: $57.04 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $416.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $617.32 | 2019-2021 | |
| Abbvie INC. | $592.28 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $461.23 | 2019-2021 | |
| Lilly USA, LLC | $430.71 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $401.30 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $368.03 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $321.35 | 2019 | |
| Amarin Pharma, INC. | $320.43 | 2019-2020 | |
| Novo Nordisk INC | $259.56 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Sanofi-Aventis U.S. LLC | $237.13 | 2019 | |
| Pfizer INC. | $183.35 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $179.09 | 2019 | |
| Glaxosmithkline, LLC. | $142.49 | 2019-2024 | Arexvy, Shingrix |
| Lundbeck LLC | $124.03 | 2023 | Vyepti |
| Grifols USA, LLC | $111.18 | 2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $100.84 | 2021 | |
| Horizon Therapeutics Plc | $94.99 | 2019 | |
| Esperion Therapeutics, INC. | $71.44 | 2020 | |
| Dexcom, INC. | $37.46 | 2024-2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $36.76 | 2023-2024 | Cologuard Collection Kit |
| Sunovion Pharmaceuticals INC. | $20.98 | 2019 | |
| Allergan, INC. | $19.44 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $19.14 | 2021 | |
| Intuitive Surgical, INC. | $18.95 | 2019 | |
| Boston Scientific Corporation | $17.07 | 2023 | Watchman Flx |
| Merck Sharp & Dohme LLC | $11.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Pecoraro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.